Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022 operating results after the close of the market on Tuesday, February 28, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.

Investors and other interested parties should register for the conference call in advance by visiting https://events.q4inc.com/attendee/430840159. Following registration, an email confirmation will be sent that includes dial-in details and unique conference call codes for entry. Registration is open throughout the call but to ensure connection for the full call, registration in advance is recommended.

The link to the webcast and audio replay will be made available at the Investor Relations website: nanostring.com.

A replay of the call will be available beginning February 28, 2023, at 7:30pm ET through midnight on March 14, 2023. To access the replay, dial (866) 813-9403 or (929) 458-6194 and reference Conference ID: 176735. The webcast will also be available on the Company's website for one year following the completion of the call.

About NanoString

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler, cited in approximately 200 peer-reviewed publications, is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics from one FFPE slide. The CosMxtm Spatial Molecular Imager is an FFPE-compatible, single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMxtm Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter® Analysis System, cited in approximately 6,500 peer-reviewed publications, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision.

For more information, please visit www.nanostring.com.


These press releases may also interest you

at 17:50
Breast Tissue Expander Market size is set to grow by USD 282.4 million from 2024-2028, Increasing prevalence of breast cancer boost the market, Technavio
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

at 17:50
Sleep Apnea Implants Market size is set to grow by USD 401.75 thousand from 2024-2028, Increasing prevalence of sleep apnea and respiratory disorders boost the market, Technavio
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...

at 17:45
Implantable Medical Devices Market size is set to grow by USD 53.5 billion from 2024-2028, Rise in number of people with chronic illnesses to boost the market growth, Technavio
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...

at 17:35
Transplant Box Market size is set to grow by USD 2.39 billion from 2024-2028, Increasing prevalence of chronic disorders boost the market, Technavio
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.87%  during the forecast period. Increasing prevalence of chronic disorders is...

at 17:31
BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...

at 17:30
Dermatology Devices Market size is set to grow by USD 154.23 billion from 2024-2028, Increasing prevalence of skin disorders to boost the market growth, Technavio
The global dermatology devices market  size is estimated to grow by USD 154.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period.  Increasing prevalence of skin...

More news about Health...


News published on and distributed by: